M. Berman

784 total citations
19 papers, 582 citations indexed

About

M. Berman is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, M. Berman has authored 19 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Reproductive Medicine, 5 papers in Obstetrics and Gynecology and 3 papers in Surgery. Recurrent topics in M. Berman's work include Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Cervical Cancer and HPV Research (3 papers). M. Berman is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Cervical Cancer and HPV Research (3 papers). M. Berman collaborates with scholars based in United States. M. Berman's co-authors include D Belpomme, John R. Lurain, Bernard Roullet, Howard D. Homesley, Graham J. Kemp, Peter S. Rose, John H. Glick, Ameda A. Manetta, P.J. DiSaia and Martin Sonenberg and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Physics in Medicine and Biology.

In The Last Decade

M. Berman

17 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Berman United States 8 172 135 134 102 94 19 582
G Aliberti Italy 13 249 1.4× 120 0.9× 96 0.7× 121 1.2× 74 0.8× 51 664
D F Hayes United States 8 464 2.7× 110 0.8× 152 1.1× 89 0.9× 21 0.2× 12 765
Thomas Helbich Austria 9 79 0.5× 136 1.0× 92 0.7× 115 1.1× 93 1.0× 18 452
B Kabakow United States 15 243 1.4× 36 0.3× 88 0.7× 208 2.0× 90 1.0× 47 734
Jin Hwa Choi South Korea 14 178 1.0× 97 0.7× 171 1.3× 139 1.4× 173 1.8× 54 771
Rümeysa Çiftçi Türkiye 16 385 2.2× 70 0.5× 249 1.9× 82 0.8× 21 0.2× 43 776
Joerg Kotzerke Germany 14 146 0.8× 371 2.7× 209 1.6× 287 2.8× 75 0.8× 27 853
Bruna Angelelli Italy 14 313 1.8× 55 0.4× 145 1.1× 156 1.5× 31 0.3× 27 609
J. Shapira Israel 14 232 1.3× 18 0.1× 149 1.1× 114 1.1× 60 0.6× 41 672
Robert F. Asbury United States 16 273 1.6× 14 0.1× 150 1.1× 124 1.2× 128 1.4× 44 653

Countries citing papers authored by M. Berman

Since Specialization
Citations

This map shows the geographic impact of M. Berman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Berman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Berman more than expected).

Fields of papers citing papers by M. Berman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Berman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Berman. The network helps show where M. Berman may publish in the future.

Co-authorship network of co-authors of M. Berman

This figure shows the co-authorship network connecting the top 25 collaborators of M. Berman. A scholar is included among the top collaborators of M. Berman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Berman. M. Berman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Sperling, Jeffrey D., et al.. (2012). Long-term outcomes of women with extramammary Paget's disease of the vulva. Gynecologic Oncology. 127(1). S30–S31. 1 indexed citations
2.
Loizzi, Vera, et al.. (2003). The Efficacy of Individualized Chemotherapy Selected by In Vitro Drug Resistance Testing for Women with Recurrence Epithelial Ovarian Cancer. CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro). 88. 246–246. 1 indexed citations
3.
Monk, Bradley J., et al.. (1997). Human Papillomavirus Type 18. Journal of Lower Genital Tract Disease. 1(3). 162–162.
4.
Kemp, Graham J., Peter S. Rose, John R. Lurain, et al.. (1996). Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.. Journal of Clinical Oncology. 14(7). 2101–2112. 365 indexed citations
5.
Brinton, LA, et al.. (1994). Past and present physical activity and endometrial cancer risk.. Rehabilitation Oncology. 12(2). 21–21. 1 indexed citations
6.
Bloss, J., S Y Liao, Alberto Manetta, et al.. (1994). Extraovarian peritoneal serous papillary carcinoma: A case‐control retrospective comparison to papillary adenocarcinoma of the ovary. International Journal of Gynecology & Obstetrics. 46(1). 87–87. 19 indexed citations
7.
Brinton, L A, et al.. (1994). 93154903 Oral contraceptives and endometrial cancer: do other risk factors modify the association?. Maturitas. 20(1). 55–55. 6 indexed citations
8.
Manetta, Alberto, et al.. (1992). Cyclosporin enhancement of cisplatin chemotherapy in patients with refractory gynecologic cancer: A gynecologic oncology group study. Gynecologic Oncology. 45(1). 80–80. 1 indexed citations
9.
DiSaia, P.J., et al.. (1992). Surgical treatment of unexpected invasive cervical cancer found at total hysterectomy.. PubMed. 80(6). 931–4. 37 indexed citations
10.
Manetta, Alberto, et al.. (1991). Radical hysterectomy in the elderly patient: Analysis of morbidity. Gynecologic Oncology. 40(2). 171–171.
11.
Berman, M., et al.. (1991). Management of endometrial cancer with suspected cervical involvement. International Journal of Gynecology & Obstetrics. 34(2). 194–194. 17 indexed citations
12.
Sutton, Gregory P., John A. Blessing, M. Berman, Howard D. Homesley, & John H. Malfetano. (1989). Phase II trial of ifosfamide and mesna in refractory epithelial ovarian carcinoma. Gynecologic Oncology. 32(1). 102–102. 1 indexed citations
13.
Berman, M., et al.. (1989). Initial surgical therapy in the management of clinical stage II endometrial cancer. Gynecologic Oncology. 32(1). 105–105. 2 indexed citations
14.
Berman, M., et al.. (1987). Skinning vulvectomy for the treatment of multifocal vulvar intraepithelial neoplasia. International Journal of Gynecology & Obstetrics. 25(6). 484–484. 20 indexed citations
15.
Ja, Blessing, et al.. (1987). Phase II trial of etoposide in the management of advanced and recurrent leiomyosarcoma of the uterus: a Gynecologic Oncology Group Study.. PubMed. 71(12). 1303–4. 27 indexed citations
16.
Micha, John P., M. Berman, Stephen G. Romansky, et al.. (1984). Malignant ovarian germ cell tumors: A review of 37 cases. Gynecologic Oncology. 17(2). 260–261. 1 indexed citations
17.
Singh, Baljinder, et al.. (1974). Kinetics of large therapy doses of 131I in patients with thyroid cancer.. PubMed. 15(8). 674–8. 8 indexed citations
18.
Berman, M., et al.. (1957). Some Physical Considerations Governing the Choice of Internally Administered Radioisotopes for Therapy. Physics in Medicine and Biology. 1(3). 243–257. 5 indexed citations
19.
Ball, Julie, et al.. (1957). RADIATION PNEUMONITIS AND FIBROSIS: A COMPLICATION OF RADIOIODINE TREATMENT OF PULMONARY METASTASES FROM CANCER OF THE THYROID*. The Journal of Clinical Endocrinology & Metabolism. 17(11). 1263–1276. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026